Clinical Trials Search Tool

A Research Study Investigating Semaglutide in People With Early Alzheimer’s Disease

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 55-85

Enrollment Opens: 04-01-2022

Enrollment Closes: TBD


This trial is called the EVOKE trial, and is sponsored by Novo Nordisk A/S. For more information, please visit

Study ID: NN6535-4730

To Enroll: Call 503-476-9788 or schedule your free over-the-phone memory screen here:

Posted by: Center for Cognitive Health |